Dose finding of oncolytic combination therapy: Essential to secure the patient's quality of life.
In: European journal of cancer (Oxford, England : 1990), Jg. 162 (2022-02-01), S. 237-240
editorialOpinion
Zugriff:
Competing Interests: Conflict of interest statement The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Titel: |
Dose finding of oncolytic combination therapy: Essential to secure the patient's quality of life.
|
---|---|
Autor/in / Beteiligte Person: | Wuyts, SC ; Schoffelen, R ; Westdorp, H ; van Erp NP |
Zeitschrift: | European journal of cancer (Oxford, England : 1990), Jg. 162 (2022-02-01), S. 237-240 |
Veröffentlichung: | Oxford : Elsevier Science Ltd ; <i>Original Publication</i>: Oxford ; New York : Pergamon Press, c1990-, 2022 |
Medientyp: | editorialOpinion |
ISSN: | 1879-0852 (electronic) |
DOI: | 10.1016/j.ejca.2021.07.022 |
Schlagwort: |
|
Sonstiges: |
|